Search details
1.
Benzamide capped peptidomimetics as non-ATP competitive inhibitors of CDK2 using the REPLACE strategy.
Bioorg Med Chem Lett
; 26(15): 3754-60, 2016 08 01.
Article
in English
| MEDLINE | ID: mdl-27297568
2.
Synthesis and evaluation of aryl boronic acids as fluorescent artificial receptors for biological carbohydrates.
Bioorg Chem
; 40(1): 137-142, 2012 Feb.
Article
in English
| MEDLINE | ID: mdl-22177855
3.
Structure-activity and mechanistic studies of non-peptidic inhibitors of the PLK1 polo box domain identified through REPLACE.
Eur J Med Chem
; 227: 113926, 2022 Jan 05.
Article
in English
| MEDLINE | ID: mdl-34735919
4.
Peptidomimetic Polo-Box-Targeted Inhibitors that Engage PLK1 in Tumor Cells and Are Selective against the PLK3 Tumor Suppressor.
ChemMedChem
; 15(12): 1058-1066, 2020 06 17.
Article
in English
| MEDLINE | ID: mdl-32232973
5.
Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors.
J Vis Exp
; (105): e52441, 2015 Oct 26.
Article
in English
| MEDLINE | ID: mdl-26554946
6.
Iterative conversion of cyclin binding groove peptides into druglike CDK inhibitors with antitumor activity.
J Med Chem
; 58(1): 433-42, 2015 Jan 08.
Article
in English
| MEDLINE | ID: mdl-25454794
7.
Current assessment of polo-like kinases as anti-tumor drug targets.
Expert Opin Drug Discov
; 9(7): 773-89, 2014 Jul.
Article
in English
| MEDLINE | ID: mdl-24819909
8.
Gold-containing indoles as anticancer agents that potentiate the cytotoxic effects of ionizing radiation.
J Med Chem
; 55(5): 2437-51, 2012 Mar 08.
Article
in English
| MEDLINE | ID: mdl-22289037
9.
Active-site-directed chemical tools for profiling mitochondrial Lon protease.
ACS Chem Biol
; 6(8): 781-8, 2011 Aug 19.
Article
in English
| MEDLINE | ID: mdl-21520912
Results
1 -
9
de 9
1
Next >
>>